Physician profile
Eric Quentin Konnick
NPI 1609190446
$26,785.58
in general payments reported to CMS, 2019-2025
11 companies · $2,668 in 2025
The $2,668 reported for 2025 was more than what a typical Molecular Genetic Pathology (Pathology) provider received nationally (typical 2025 total: $225).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2022: $6,613 · 2023: $13K · 2024: $2,747 · 2025: $2,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $1,789 · Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,454.25 |
| Travel and Lodging | $1,788.75 |
| Food and Beverage | $430.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $4,551.35 | 2023 | Opdivo |
| Roche Diagnostics Corporation | $3,560.00 | 2022 | |
| Amgen INC. | $3,495.00 | 2023 | |
| Astrazeneca Uk Limited | $2,722.50 | 2024 | Lynparza |
| Astrazeneca Pharmaceuticals LP | $2,692.44 | 2024-2025 | Truqap |
| Bristol Myers Squibb Company | $2,644.57 | 2023 | |
| Genzyme Corporation | $2,017.22 | 2023 | |
| Merck Sharp & Dohme LLC | $1,907.50 | 2022 | |
| Ventana Medical Systems, INC. | $1,500.00 | 2019 | |
| Agilent Technologies, INC. | $1,145.00 | 2022 | |
| Abbvie INC. | $550.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Konnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.